Sep 22, 2026 7 0
Uploaded by Evangeline
Favorite
Share
More Options
23
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy_Page 1

Open in WPS to view all 23 pages